COGT
Cogent Biosciences, Inc.NASDAQHealthcare$35.21-0.09%ClosedMarket Cap: $5.71B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.76
P/S
0.00
EV/EBITDA
-17.07
DCF Value
$0.74
FCF Yield
-4.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-100.2%
ROA
-35.1%
ROIC
-38.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-99.5M | $-102.5M | $-0.69 | — |
| FY 2025 | $0.00 | -Infinity% | $-333.4M | $-328.9M | $-2.55 | — |
| Q3 2025 | $0.00 | NaN% | $-83.4M | $-80.9M | $-0.71 | — |
| Q2 2025 | $0.00 | -Infinity% | $-75.6M | $-73.5M | $-0.64 | — |
| Q1 2025 | $0.00 | NaN% | $-74.9M | $-72.0M | $-0.52 | — |
| Q4 2024 | $0.00 | NaN% | $-73.7M | $-67.9M | $-0.61 | — |
| FY 2024 | $0.00 | NaN% | $-275.9M | $-255.9M | $-2.46 | — |
| Q3 2024 | $0.00 | NaN% | $-75.4M | $-70.6M | $-0.64 | — |
| Q2 2024 | $0.00 | NaN% | $-64.4M | $-59.0M | $-0.59 | — |
| Q1 2024 | $0.00 | NaN% | $-62.4M | $-58.3M | $-0.62 | — |
| Q4 2023 | $0.00 | NaN% | $-58.2M | $-54.4M | $-0.63 | — |
| FY 2023 | $0.00 | NaN% | $-208.1M | $-192.4M | $-2.42 | — |